Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Article Details
- CitationCopy to clipboard
Engel G, Hofmann U, Heidemann H, Cosme J, Eichelbaum M
Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Clin Pharmacol Ther. 1996 Jun;59(6):613-23.
- PubMed ID
- 8681486 [ View in PubMed]
- Abstract
BACKGROUND AND OBJECTIVE: Antipyrine has been widely used as a probe drug for human oxidative drug metabolism. To evaluate the role of antipyrine as a model drug, we have identified the cytochrome P450 enzymes involved in 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation. METHODS: We used the following methods for this study: (1) determination of enzyme kinetics for antipyrine metabolite formation in human liver microsomes, (2) inhibition studies with antibodies and inhibitors, and (3) formation of metabolites by stable expressed human P450 enzymes. RESULTS: Antipyrine biotransformation could be described by Michaelis-Menten kinetics: norantipyrine: maximum rate of metabolite formation (Vmax), 0.91 +/- 0.04 nmol . mg-1 . min-1; Michaelis-Menten constant (Km), 19.0 +/- 0.8 mmol/L; 4-hydroxyantipyrine: Vmax, 1.54 +/- 0.08 nmol . mg-1 . min-1;Km,39.6 +/- 2.5 mmol/L. Antibodies against CYP3A4 inhibited the formation of 4-hydroxyantipyrine by 25% to 65%. LKM-2 antibodies (anti-CYP2C) caused a 75% to 100% inhibition of norantipyrine and a 58% to 80% inhibition of 3-hydroxymethylantipyrine formation. Sulfaphenazole inhibited the formation of 3-hydroxymethylantipyrine and norantipyrine by about 50%. Furafylline and fluvoxamine inhibited norantipyrine, 4-hydroxyantipyrine, and 3-hydroxymethylantipyrine formation by about 30%, 30%, and 50%, respectively. Ketoconazole reduced formation of norantipyrine, 3-hydroxymethylantipyrine, and 4-hydroxyantipyrine by up to 80%. Formation in stable expressed enzymes indicated involvement of CYP1A2, CYP2B6, CYP2C, and CYP3A4 in metabolite formation. CONCLUSION: Antipyrine metabolites are formed by at least six hepatic cytochrome P450 enzymes (CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C18, and CYP3A4). 4-Hydroxylation is mainly catalyzed by CYP3A4 and, to a lesser extent, by CYP1A2. The CYP2C subfamily contains the predominant enzymes for norantipyrine formation, and CYP1A2 is also involved. Formation of 3-hydroxymethylantipyrine is mediated by CYP1A2 and CYP2C9. Because several cytochrome P450 enzymes are involved in the formation of each metabolite, antipyrine is not well suited as a probe for distinct human cytochrome P450 enzymes.
DrugBank Data that Cites this Article
- Drug Enzymes
Drug Enzyme Kind Organism Pharmacological Action Actions Antipyrine Cytochrome P450 1A2 Protein Humans UnknownSubstrateDetails Antipyrine Cytochrome P450 2B6 Protein Humans UnknownSubstrateDetails Antipyrine Cytochrome P450 2C18 Protein Humans UnknownSubstrateDetails Antipyrine Cytochrome P450 2C19 Protein Humans UnknownSubstrateDetails Antipyrine Cytochrome P450 2C8 Protein Humans UnknownSubstrateDetails Antipyrine Cytochrome P450 2C9 Protein Humans UnknownSubstrateDetails Antipyrine Cytochrome P450 2D6 Protein Humans UnknownSubstrateDetails Antipyrine Cytochrome P450 3A4 Protein Humans UnknownSubstrateDetails - Drug Interactions
Drugs Interaction Integrate drug-drug
interactions in your softwareAcenocoumarolSomatrem The metabolism of Acenocoumarol can be increased when combined with Somatrem. AcenocoumarolAlbusomatropin The metabolism of Acenocoumarol can be increased when combined with Albusomatropin. AcenocoumarolSomatropin pegol The metabolism of Acenocoumarol can be increased when combined with Somatropin pegol. AcetaminophenSomatrem The metabolism of Acetaminophen can be increased when combined with Somatrem. AcetaminophenAlbusomatropin The metabolism of Acetaminophen can be increased when combined with Albusomatropin.